Literature DB >> 7990626

[The effectiveness of standardized follow-up studies after resection of non-small cell bronchial carcinoma].

H U Zieren1, J M Müller, D Petermann, H Pichlmaier.   

Abstract

The outcomes of 190 patients in whom a non-small-cell bronchogenic carcinoma had been resected with curative intent in the Department of Surgery, University of Cologne, between 1. 1. 1977 and 31. 12. 1987 were analysed retrospectively. Sixty-seven (35%) of these patients underwent regular, 64 (34%) irregular, and 59 (31%) no standardized follow-up programmes. During follow-up procedures tumour recurrences were detected in 33 patients (25%). Thirteen (39%) of these recurrences were completely asymptomatic at the time of diagnosis. Three recurrences (9%) were resected with curative intent, but the patients died between 14 and 17 months later due to recurrent disease. Seven recurrences (21%) were treated by radiotherapy, three (9%) by chemotherapy, and 20 patients (61%) received no oncologic therapy. The survival rates after diagnosis of recurrence were not affected by the type of treatment or by the presence of clinical symptoms. There is no evidence that long-term results following resection of non-small-cell bronchogenic carcinoma can be improved by regular and standardized follow-up programmes. The observed incidence of postoperative pulmonary disorders and the patients' self-assessment underline the necessity for postoperative care after resection of bronchogenic carcinoma. Apart from clinical studies, follow-up should primarily focus on individual symptoms and should no longer include standardized investigations in asymptomatic patients except occasional X-ray checks of the thorax.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990626     DOI: 10.1007/BF00186397

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  17 in total

1.  [Follow-up in stomach carcinoma].

Authors:  B Böhm; J Osswald; W Stock
Journal:  Leber Magen Darm       Date:  1991-03

2.  Bronchial stump recurrence after surgery for bronchial carcinoma.

Authors:  G Verleden; G Deneffe; M Demedts
Journal:  Eur Respir J       Date:  1990-01       Impact factor: 16.671

3.  [Current aspects of a new staging classification of bronchial cancer and its clinical consequences].

Authors:  I Vogt-Moykopf; D Branscheid; H Bülzebruck; G Probst
Journal:  Chirurg       Date:  1989-01       Impact factor: 0.955

4.  Radiation therapy for postoperative local-regionally recurrent lung cancer.

Authors:  G Kopelson; N C Choi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-11       Impact factor: 7.038

5.  Reoperation for bronchial carcinoma.

Authors:  A Gabler; S Liebig
Journal:  Thorax       Date:  1980-09       Impact factor: 9.139

6.  Value of radiotherapy for tumour on the bronchial stump after resection for bronchial carcinoma.

Authors:  M R Law; J M Henk; S C Lennox; M E Hodson
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

7.  Surgical treatment of multiple primary lung cancers.

Authors:  A F Verhagen; H J van de Wal; A L Cox; L K Lacquet
Journal:  Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 1.827

8.  Successful treatment of adrenal metastases from large-cell carcinoma of the lung.

Authors:  P Twomey; C Montgomery; O Clark
Journal:  JAMA       Date:  1982-08-06       Impact factor: 56.272

9.  Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?

Authors:  W J Curran; S H Herbert; P M Stafford; H M Sandler; S A Rosenthal; W G McKenna; E Hughes; M J Dougherty; S Keller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

10.  [Differential after care for early detection of recurrence: from the surgical viewpoint].

Authors:  A Altendorf-Hofmann; J Scheele
Journal:  Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.